These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 23107421

  • 1. Early life intervention with glucocorticoids has negative effects on motor development and neuropsychological function in 14-17 year-old adolescents.
    ter Wolbeek M, de Sonneville LM, de Vries WB, Kavelaars A, Veen S, Kornelisse RF, van Weissenbruch M, Baerts W, Liem KD, van Bel F, Heijnen CJ.
    Psychoneuroendocrinology; 2013 Jul; 38(7):975-86. PubMed ID: 23107421
    [Abstract] [Full Text] [Related]

  • 2. Neonatal glucocorticoid treatment: long-term effects on the hypothalamus-pituitary-adrenal axis, immune system, and problem behavior in 14-17 year old adolescents.
    Ter Wolbeek M, Kavelaars A, de Vries WB, Tersteeg-Kamperman M, Veen S, Kornelisse RF, van Weissenbruch M, Baerts W, Liem KD, van Bel F, Heijnen CJ.
    Brain Behav Immun; 2015 Mar; 45():128-38. PubMed ID: 25449580
    [Abstract] [Full Text] [Related]

  • 3. Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone.
    Karemaker R, Heijnen CJ, Veen S, Baerts W, Samsom J, Visser GH, Kavelaars A, van Doornen LJ, van Bel F.
    Pediatr Res; 2006 Dec; 60(6):745-50. PubMed ID: 17065571
    [Abstract] [Full Text] [Related]

  • 4. Functional outcome at school age of preterm-born children treated with high-dose dexamethasone.
    Hitzert MM, Van Braeckel KN, de Bok M, Maathuis CG, Roze E, Bos AF.
    Early Hum Dev; 2014 May; 90(5):253-8. PubMed ID: 24602475
    [Abstract] [Full Text] [Related]

  • 5. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.
    Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH.
    N Engl J Med; 2004 Mar 25; 350(13):1304-13. PubMed ID: 15044641
    [Abstract] [Full Text] [Related]

  • 6. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
    Yoder BA, Harrison M, Clark RH.
    Pediatrics; 2009 Aug 25; 124(2):673-9. PubMed ID: 19620192
    [Abstract] [Full Text] [Related]

  • 7. Effects of neonatal corticosteroid treatment on hippocampal synaptic function.
    Huang CC, Lin HR, Liang YC, Hsu KS.
    Pediatr Res; 2007 Sep 25; 62(3):267-70. PubMed ID: 17622955
    [Abstract] [Full Text] [Related]

  • 8. Neuropsychological and behavioral effects of postnatal dexamethasone in extremely low birth weight preterm children at early school age.
    Crotty KC, Ahronovich MD, Baron IS, Baker R, Erickson K, Litman FR.
    J Perinatol; 2012 Feb 25; 32(2):139-46. PubMed ID: 21546939
    [Abstract] [Full Text] [Related]

  • 9. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
    Hitzert MM, Benders MJ, Roescher AM, van Bel F, de Vries LS, Bos AF.
    Pediatr Res; 2012 Jan 25; 71(1):100-6. PubMed ID: 22289857
    [Abstract] [Full Text] [Related]

  • 10. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children.
    Rademaker KJ, Uiterwaal CS, Groenendaal F, Venema MM, van Bel F, Beek FJ, van Haastert IC, Grobbee DE, de Vries LS.
    J Pediatr; 2007 Apr 25; 150(4):351-7. PubMed ID: 17382109
    [Abstract] [Full Text] [Related]

  • 11. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
    Watterberg KL, American Academy of Pediatrics. Committee on Fetus and Newborn.
    Pediatrics; 2010 Oct 25; 126(4):800-8. PubMed ID: 20819899
    [Abstract] [Full Text] [Related]

  • 12. Functioning of 7-year-old children born at 32 to 35 weeks' gestational age.
    Cserjesi R, Van Braeckel KN, Butcher PR, Kerstjens JM, Reijneveld SA, Bouma A, Geuze RH, Bos AF.
    Pediatrics; 2012 Oct 25; 130(4):e838-46. PubMed ID: 22945414
    [Abstract] [Full Text] [Related]

  • 13. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone.
    Aghai ZH, Faqiri S, Saslow JG, Nakhla T, Farhath S, Kumar A, Eydelman R, Strande L, Stahl G, Leone P, Bhandari V.
    J Perinatol; 2008 Feb 25; 28(2):149-55. PubMed ID: 18033304
    [Abstract] [Full Text] [Related]

  • 14. Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?
    van der Heide-Jalving M, Kamphuis PJ, van der Laan MJ, Bakker JM, Wiegant VM, Heijnen CJ, Veen S, van Bel F.
    Acta Paediatr; 2003 Jul 25; 92(7):827-35. PubMed ID: 12892163
    [Abstract] [Full Text] [Related]

  • 15. Transient increase in intraocular pressure during a dose-tapering regime of systemic dexamethasone in preterm infants.
    Ng PC, Lee CH, Tam BS, Wong SP, Lam HS, Kwok AK, Fok TF.
    Ophthalmology; 2008 May 25; 115(5):e7-14. PubMed ID: 18321580
    [Abstract] [Full Text] [Related]

  • 16. Dexamethasone induces neurodegeneration but also up-regulates vascular endothelial growth factor A in neonatal rat brains.
    Feng Y, Rhodes PG, Liu H, Bhatt AJ.
    Neuroscience; 2009 Jan 23; 158(2):823-32. PubMed ID: 19007863
    [Abstract] [Full Text] [Related]

  • 17. Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero.
    Brucato A, Astori MG, Cimaz R, Villa P, Li Destri M, Chimini L, Vaccari R, Muscarà M, Motta M, Tincani A, Neri F, Martinelli S.
    Ann Rheum Dis; 2006 Nov 23; 65(11):1422-6. PubMed ID: 16504990
    [Abstract] [Full Text] [Related]

  • 18. Dexamethasone dosing, mechanical ventilation and the risk of cerebral palsy.
    Powell K, Kerkering KW, Barker G, Rozycki HJ.
    J Matern Fetal Neonatal Med; 2006 Jan 23; 19(1):43-8. PubMed ID: 16492591
    [Abstract] [Full Text] [Related]

  • 19. Trial of early neonatal hydrocortisone: two-year follow-up.
    Peltoniemi OM, Lano A, Puosi R, Yliherva A, Bonsante F, Kari MA, Hallman M, Neonatal Hydrocortisone Working Group.
    Neonatology; 2009 Jan 23; 95(3):240-7. PubMed ID: 18931525
    [Abstract] [Full Text] [Related]

  • 20. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ, Anbar RD, Mettelman BB.
    Pediatrics; 2005 Mar 23; 115(3):681-7. PubMed ID: 15741372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.